Paul T. Schumacker, PhD, MEng, ATSF, FERS

Basic and Preclinical Science
Injury, Repair, and Regeneration
Schumacker Laboratory
Pronouns: He, Him, His

“If you need to do something new, talk to people who already know how to do it.”

Research Interests

  • Hypoxia
  • Cancer
  • Metabolism
  • Mitochondria
  • Cell Signaling

Biography

  • Patrick M. Magoon Distinguished Professor in Neonatal Research, Ann & Robert H. Lurie Children’s Hospital of Chicago
  • Professor of Pediatrics, Cell and Molecular Biology, and Medicine, Northwestern University Feinberg School of Medicine

Education and Background

  • Fellowship, Section of Respiratory Physiology, University of California San Diego 1978-1983
  • PhD, Physiology, Albany Medical College 1980
  • MEng, Biomedical Engineering, Rensselaer Polytechnic Institute 1976
  • BS, Biomedical Engineering, Rensselaer Polytechnic Institute 1974

Research Highlights

MITOCHONDRIAL FUNCTIONS REGULATE CARDIOMYOCYTE PROLIFERATION

This project examines the role of mitochondria in regulating cell proliferation in the heart. Newborn heart cells are capable of undergoing cell division, which can repair heart damage with new muscle cells during the perinatal period. However, soon after birth, these cells transition from fetal myocytes into adult heart cells that have lost the ability to divide. After this transition has occurred, damaged hearts are repaired with scar tissue, which interferes with normal contraction and can contribute to heart failure. We have discovered that mitochondria regulate the heart cell's transition from mitosis-competent into a post-mitotic state. During that transition, the heart cells switch from a fetal reliance on glycolysis to the adult reliance on oxidative phosphorylation. Forcing the adult heart cells to return to a reliance on glycolysis causes a re-awakening of their ability to undergo cell division, and the hearts grow in size by turning on gene pathways associated with cardiac development. This response, when activated concurrently with the induction of ischemic injury, results in the migration of new heart cells into the region of cell damage, opening the possibility that this response could be used to repair under-developed left hearts in newborns, or to repair ischemic damage in adult hearts.

Similar Researchers

Clinical and Community Trials

Research Interests

Critical Care, Viral Respiratory Infections, Lung Injury and Repair, Immune Regulation

Recent Publication

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Basic and Preclinical Science

Yongchao Ma, PhD

Ma Laboratory

Research Interests

Neurobiology

Basic and Preclinical Science

Joon Won Yoon, PhD

Research Assistant Professor

Research Interests

Microbial—Host Interaction, Microbial Adherence, Microbiology

Recent Publication

CRISPR editing of the GLI1 first intron abrogates GLI1 expression and differentially alters lineage commitment.

Basic and Preclinical Science

Gal Finer, MD, PhD

Finer Laboratory

Research Interests

Kidney Development, Renal Progenitors, Tissue Regeneration, Chronic Kidney Disease, Congenital Anomalies of the Kidney

Recent Publication

Does History of Prematurity Prompt Blood Pressure Evaluations at Primary Care Visits

Clinical and Community Trials

Research Interests

Cystic Fibrosis, Health Equity, Newborn Screening, Therapeutic and Device Development

Recent Publication

Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study.

Clinical and Community Trials

Research Interests

Autonomic Medicine, Circadian Rhythms, Developmental Neurobiology, Developmental Genetics, Endocrine Genetics, Pacemakers, Respiratory Diseases, Sudden Cardiac Death

Recent Publication

Evolution of physiologic and autonomic phenotype in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation over a decade from age at diagnosis.